Citation Impact
Citing Papers
Peptide-Loaded Langerhans Cells, Despite Increased IL15 Secretion and T-Cell Activation In Vitro , Elicit Antitumor T-Cell Responses Comparable to Peptide-Loaded Monocyte-Derived Dendritic Cells In Vivo
2011
Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responses
2006 StandoutNobel
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
2004 Standout
Global Cancer Incidence and Mortality Rates and Trends—An Update
2015 Standout
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
2010 Standout
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
Phenotype, Function, and Gene Expression Profiles of Programmed Death-1hi CD8 T Cells in Healthy Human Adults
2011
Expression of Interleukin-15 and Interleukin-15Rα in Monocytes of HIV Type 1-Infected Patients with Different Courses of Disease Progression
2011
The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
2009 StandoutNobel
HIV Envelope Suppresses CD4+ T Cell Activation Independent of T Regulatory Cells
2008 StandoutNobel
Cancer Statistics, 2021
2021 Standout
Regulation of microRNA function in animals
2018 Standout
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape
2018
IL-15: targeting CD8+T cells for immunotherapy
2005
High dose of plasmid IL-15 inhibits immune responses in an influenza non-human primates immunogenicity model
2009
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
2007 Standout
Quantum dots versus organic dyes as fluorescent labels
2008 Standout
T cell exhaustion
2011 Standout
Multi-input chemical control of protein dimerization for programming graded cellular responses
2019 StandoutNobel
Coinfection With HIV-1 and HCV—A One-Two Punch
2009
The importance of resistance to direct antiviral drugs in HCV infection in clinical practice
2015
Hepatitis C
2015
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Beyond six colors: A new era in flow cytometry
2003
Cancer immunotherapy via dendritic cells
2012 Standout
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
2006 Standout
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
2011 StandoutNobel
Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection
2016
Emerging Therapeutic Targets for Hepatitis C Virus Infection
2013
Lessons from the study of T-cell differentiation in persistent human virus infection
2004
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Functional Impairment of CD8+ T Cells by Regulatory T Cells during Persistent Retroviral Infection
2004 StandoutNobel
Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression
2016
Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development
2010 StandoutNobel
Update on hepatitis C virus resistance to direct-acting antiviral agents
2014
Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection
2016
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
Negative regulators of T‐cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
2009 StandoutNobel
Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancer
2014 StandoutNobel
Antiviral therapy of hepatitis C in 2014: Do we need resistance testing?
2014
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
2008 Standout
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
2007 Standout
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Hepatitis C Virus: 30 Years after Its Discovery
2019 StandoutNobel
Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens
2016
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
2006 Standout
Extrahepatic Morbidity and Mortality of Chronic Hepatitis C
2015
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Molecular and cellular insights into T cell exhaustion
2015 Standout
Lineage relationship and protective immunity of memory CD8 T cell subsets
2003 Standout
HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors
2002
Levels of CD56+TIM-3- Effector CD8 T Cells Distinguish HIV Natural Virus Suppressors from Patients Receiving Antiretroviral Therapy
2014
CD8+ T Cells Specific for EBV, Cytomegalovirus, and Influenza Virus Are Activated during Primary HIV Infection
2004
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment
2003
Lack of IL-15 results in the suboptimal priming of CD4+T cell response against an intracellular parasite
2006
Variable Patterns of Programmed Death-1 Expression on Fully Functional Memory T Cells after Spontaneous Resolution of Hepatitis C Virus Infection
2008 StandoutNobel
Augmented IL-15Rα Expression by CD40 Activation Is Critical in Synergistic CD8 T Cell-Mediated Antitumor Activity of Anti-CD40 Antibody with IL-15 in TRAMP-C2 Tumors in Mice
2012 StandoutNobel
Protease inhibitor therapy for hepatitis C virus-infection
2018
Neonatal Natural Killer Cell Function: Relevance to Antiviral Immune Defense
2013
Evolution of the immune system in humans from infancy to old age
2015 Standout
Broadly neutralizing antibodies abrogate established hepatitis C virus infection
2014 StandoutNobel
Virologic Tools for HCV Drug Resistance Testing
2015
Resistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical Implications
2015
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection
2017
T Cell Dynamics in HIV-1 Infection
2003
Screening for Hepatitis C Virus Infection in Adolescents and Adults
2020
The Programmed Death-1 and Interleukin-10 Pathways Play a Down-Modulatory Role in LP-BM5 Retrovirus-Induced Murine Immunodeficiency Syndrome
2007 StandoutNobel
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection
2006
Combined IL-15/IL-15Rα Immunotherapy Maximizes IL-15 Activity In Vivo
2006
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Chronic Antigen Stimulation Alone Is Sufficient to Drive CD8+ T Cell Exhaustion
2009
Impact of Epitope Escape on PD-1 Expression and CD8 T-Cell Exhaustion during Chronic Infection
2009
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Reduction of Retrovirus-Induced Immunosuppression by In Vivo Modulation of T Cells during Acute Infection
2004 StandoutNobel
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells
2019 StandoutNobel
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Perspectives on HCV: Current Therapeutic Regimens and Drug–Drug Interactions
2017
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
2016 StandoutNobel
IL-15: targeting CD8+ T cells for immunotherapy
2005
SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection
2007
PD-1 and Its Ligands in Tolerance and Immunity
2008 Standout
Distinct Mechanisms of CD4+and CD8+T-Cell Activation and Bystander Apoptosis Induced by Human Immunodeficiency Virus Type 1 Virions
2005
Barrier-Independent, Fitness-Associated Differences in Sofosbuvir Efficacy against Hepatitis C Virus
2016 StandoutNobel
T-Cell Subsets That Harbor Human Immunodeficiency Virus (HIV) In Vivo: Implications for HIV Pathogenesis
2004
Works of James Witek being referenced
Increased CD95/Fas-Induced Apoptosis of HIV-Specific CD8+ T Cells
2001
Telaprevir combination therapy in HCV/HIV co‐infected patients (INSIGHT study): sustained virologic response at 12 weeks final analysis
2014
Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region
2015
Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1‐infected patients without cirrhosis: OPTIMIST‐1, a phase 3, randomized study
2016
OPTIMIZE trial: Non-inferiority of twice-daily telaprevir versus administration every 8 hours in treatment-naïve, genotype 1 HCV infected patients
2013
HIV-Specific CD8+ T Cells Exhibit Markedly Reduced Levels of Bcl-2 and Bcl-xL
2004
Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST‐2)
2015
Evolution of Hepatitis C Virus Quasispecies during Repeated Treatment with the NS3/4A Protease Inhibitor Telaprevir
2015
IL-15 enhances survival and function of HIV-specific CD8+ T cells
2003
Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial
2013
898 TREATMENT WITH TELAPREVIR/PEG-IFN/RBV AFTER 14-DAY TELAPREVIR EXPOSURE IN PHASE I STUDIES: RESULTS FROM THE PHASE IIIB C219 ROLLOVER STUDY
2013
Pharmacokinetic Interaction between Telaprevir and Methadone
2013